Antifungal susceptibility patterns of yeast isolates causing bloodstream infections

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 2, 2003, Pages 431-433

  Barchiesi, Francesco ^a   Caggiano, Giuseppina ^b   Maracci, Monia ^a   Arzeni, Daniela ^a   Scalise, Giorgio ^a   Montagna, Maria Teresa ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Antifungal susceptibility; Yeast isolates

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CONTROLLED STUDY; DILUTION; FUNGEMIA; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITAL PATIENT; HUMAN; ITALY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION;

ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; YEASTS;

EID: 0037328985     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg073     Document Type: Article

References (5)

1. Pfaller, M. A., Diekema, D. J., Jones, R. N., Sader, H. S., Fluit, A. C., Hollis, R. J. et al. (2001). International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. Journal of Clinical Microbiology 39, 3254-9.
2. Barry, A. L., Pfaller, M. A., Brown, S. D., Espinel-Ingroff, A., Ghannoum, M. A., Knapp, C. et al. (2000). Quality control limits for broth microdilution susceptibility tests of 10 antifungal agents. Journal of Clinical Microbiology 38, 3457-9.
3. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS, Wayne, PA, USA.
4. Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A. et al. (1997). Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clinical Infectious Diseases 24, 235-47.
5. Nguyen, M. H., Clancy, C. J., Yu, V. L., Yu, Y. C., Morris, A. J., Snydman, D. R. et al. (1998). Do in vitro susceptibility data predict the microbiological response to amphotericin B? Results of a prospective study of patients with Candida fungemia. Journal of Infectious Diseases 177, 425-30.